AKT1 and lung cancer: A combinatorial treatment with cisplatin and perifosine reduced the growth of lung cancer cells in vitro and in xenografted mouse models more effectively than single treatments, clearly showing the involvement of the MACC1-mediated activation of the PI3K/AKT signaling pathway on chemo-resistance.